OPNET Technologies, Inc. (Nasdaq:OPNT), a leading provider of solutions for managing applications and networks, today announced that its ACE Live Rover software appliance for end-user experience monitoring is now available for purchase online. Visitors can also request a product evaluation.

ACE Live Rover is an affordable and powerful software appliance that automatically analyzes application performance problems to assist IT staff in determining the root cause. It can be implemented in just minutes to monitor end-user experience, measure end-to-end response time, and troubleshoot application and network performance problems.

"ACE Live Rover offers breakthrough functionality at an exceptionally low price and this low price point has enabled OPNET to introduce its first product via an online, self-serve sales process," stated Marc Cohen, OPNET Chairman and CEO. "Rover is particularly well suited to enterprises with remote branch offices as a low-cost option for extending enterprise-class application performance management into those remote environments. ACE Live Rover is also an ideal solution for small and medium businesses, enabling them to monitor all their users and applications from their central data center or server farm. It offers great ease of use, rich application and network management capabilities, and low TCO."

Free trials are available through OPNET's website. In addition, ACE Live Rover is also available through the online VMware Marketplace sponsored by VMware, Inc.

Availability

ACE Live Rover is available now for online purchase from OPNET Technologies, Inc. at http://www.opnet.com/ACE-Live-Rover

About OPNET Technologies, Inc.

Founded in 1986, OPNET Technologies, Inc. (Nasdaq:OPNT) is a leading provider of solutions for managing applications and networks. For more information about OPNET and its products, please visit www.opnet.com.

OPNET, OPNET Technologies, Inc., and ACE Live are trademarks of OPNET Technologies, Inc. All other trademarks are the property of their respective owners.

Statements in this press release that are not purely historical facts may constitute forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. OPNET Technologies, Inc. ("OPNET") assumes no obligation to update statements. Forward-looking statements are predictions based upon information available to OPNET as of the date of this press release and involve risks and uncertainties; therefore, actual events or results may differ materially. For a discussion of risk factors, see OPNET's reports, including its most recent 10-Q and 10-K, filed with the Securities & Exchange Commission.

CONTACT: OPNET Technologies, Inc.

Media Contact:

Margarita Castillo

(240) 497-3000

Media@opnet.com

Investor Relations:

Mel F. Wesley

(240) 497-3000

ir@opnet.com

Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more Opiant Pharmaceuticals Charts.
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more Opiant Pharmaceuticals Charts.